The objective: to explore clinico-epidemiological aspects of parkinsonism in the Yaroslavl region. One thousand patients were examined in the movement disorders outpatient clinics in 2007–2010. We used standard criteria for the diagnostics of extrapyramidal disorders and the following scales: UPDRS, Hoehn–Yahr and Schwab–England. On observation, 53% of patients were from Yaroslavl and 37% from the Yaroslavl region. 474 (47%) patients were diagnosed with Parkinson disease, 62 (6.2%) with vascular parkinsonism, 17 (1.7%) with parkinsonism-plus, 8 (0.8%) with neuroleptic parkinsonism, 1 (0.1%) with post-encephalitic parkinsonism and 1 (0.1%) with parkinsonism caused by brain tumor. Women prevailed among Parkinson’s disease patients (1 : 1.5). Most patients (71%) were from 60 to 75 years of age. 18% of patients had stage 5 of PD, 50% had stage 2, 27% had stage 3 and 5% had stage 4. A mixed form of the disease prevailed (71%); an akinetic-rigid form (23%) and a trembling form (5%) occurred more rarely. In 58% of patients an intermediate rate of progression was observed, in 22% of patients progression was rapid and in 20% of patients it was slow. In general, our results correspond to international findings. Activity of a specialized movement disorders center improve diagnostics, treatment and quality of life of patients with Parkinson’s disease.
Parkinsonism in in the Yaroslavl region: clinico-epidemiological aspects and a working experience of a specialized center
- Authors: Pizova N.V.1, Bykanova M.A.2, Kurapin E.V.3, Kоvalchuk A.Y.4
-
Affiliations:
- Yaroslavl' State Medical University
- Yaroslavl State Medical University
- Yaroslavl Regional Clinical Hospital
- Yaroslavl State Medical Academy
- Issue: Vol 5, No 2 (2011)
- Pages: 18-23
- Section: Original articles
- Submitted: 03.02.2017
- Published: 13.02.2017
- URL: https://annaly-nevrologii.com/journal/pathID/article/view/309
- DOI: https://doi.org/10.17816/psaic309
- ID: 309
Cite item
Full Text
Abstract
Keywords
About the authors
Natalia V. Pizova
Yaroslavl' State Medical University
Email: pizova@yandex.ru
Россия, Yaroslavl'
Maria A. Bykanova
Yaroslavl State Medical University
Email: pizova@yandex.ru
Россия, Yaroslavl
Eugeny V. Kurapin
Yaroslavl Regional Clinical Hospital
Email: pizova@yandex.ru
Россия, Yaroslavl
A. Yu. Kоvalchuk
Yaroslavl State Medical Academy
Author for correspondence.
Email: pizova@yandex.ru
Россия, Yaroslavl
References
- Артемьев Д.В. Возрастные аспекты болезни Паркинсона. Автореф. Дис. … канд. мед. наук. М., 1995.
- Атаджанов М.А. Экспериментальное моделирование паркин- сонического синдрома и его комплексная патогенетическая терапия. Автореф. дис. … докт. мед. наук. М., 1989.
- Вейн A.M., Голубев В.Л., Берзиньш Ю.Э. Паркинсонизм. Клиника, этиология, патогенез, лечение. Рига: Зинатне, 1981.
- Глозман Ж.М., Артемьев Д.В., Дамулин И.В. и др. Возрастные особенности нейропсихологических расстройств при болезни Паркинсона. Вестник МГУ. Психология 1994; 3: 25–36.
- Голубев В.Л., Левин Я.И., Вейн A.M. Болезнь Паркинсона и синдром паркинсонизма. М., МЕДпресс-информ, 2000.
- Докадина Л.В. Паркинсонизм: Клинико-эпидемиологические аспекты и состояние амбулаторной помощи на региональном уровне. Автореф. дис. … канд. мед. наук. М., 2004.
- Жученко Т.Д., Вейн A.M., Голубев В.Л. и др. Сосудистый пар- кинсонизм. Журн. неврол. психиатрии им. С.С. Корсакова 1998; 4: 62–65.
- Левин О.С. Клинико-нейропсихологические и нейровизуали- зационные аспекты дифференциальной диагностики паркинсо- низма. Дис. … докт. мед. наук. М., 2003.
- Левин О.С. Сосудистый паркинсонизм. Неврол. журн. 1997; 4: 42–51.
- Роменская Л.Х. Вопросы эпидемиологии, клиники и фармако- терапии паркинсонизма. Автореф. дис. … канд. мед. наук. М., 1976.
- Смоленцева И.Г. Влияние агонистов дофаминовых рецепто- ров на двигательные и нейропсихологические расстройства у больных с болезнью Паркинсона. Дис. … канд. мед. наук. М., 2000.
- Федорова Н.В. Лечение болезни Паркинсона. Русский мед. журн. 2001; 2: 24–33.
- Шток В.Н., Иванова-Смоленская И.А., Левин О.С. (ред.) Экстрапирамидные расстройства. Руководство по диагностике и лечению. М., МЕДпресс-информ, 2002.
- Шток В.Н., Левин О.С., Федорова Н.В. Экстрапирамидные рас- стройства. Учебное пособие. М., 1998.
- Шток В.Н., Федорова Н.В. Лечение паркинсонизма. М., 1997.
- Шток В.Н., Федорова Н.В. Медикаментозное лечение паркин- сонизма. Вестн. практич. неврол. 1995; 1: 40–42.
- Яхно Н.Н. Современные подходы к лекарственному лечению болезни Паркинсона. Клин. фармакол. тер. 1994; 3–4: 92–97.
- Яхно Н.Н., Штульман Д.Р., Мельничук П.В. Паркинсонизм. В кн.: Болезни нервной системы, Т.2. М.,1995: 144–159.
- Ashok P.P., Radhakrishnan K., Sridharan R., Mousa M.E. Epidemiology of Parkinson’s disease in Benghazi, North-East Libya. Clin. Neurol. Neurosurg. 1986; 88: 109–113.
- Baldereschi M.A., Di Carlo W.A.Working Group Parkinson’s disease and parkinsonism in a longitudinal study. Two-fold higher incidence in men. Neurology 2000; 55: 1358–1363.
- Benito-Leon J. Prevalence of Parkinson’s disease and other types of parkinsonism in three olderis populations of central Spain. Mov. Disord. 2003; 18: 267–274.
- Bharucha N.E., Bharucha E.P. Prevalence of Parkinson’s disease in the Parsi community of Bombay, India. Arch. Neurol.1988; 45; 1321–1323.
- Bower J.H., Maraganore D.M., McDonnell S.K. et al. Influence of strict, intermediate, and broad diagnostic criteria on the age- and sexspecific incidence of Parkinson’s disease. Mov. Disord. 2000; 15: 819–825.
- Brewis M., Poskanzer D.C., Rolland C., Miller H. Neurological disease in an English city. Acta Neurol. Scand. 1966; 42; 1–89.
- Cardoso F., Jankovic J. Periperally indused tremor and parkinsonism. Arch. Neurol.1995; 52: 263–270.
- Caroline M., Goldman S.M. Epidemiology of Parkinson’s disease. Neuroepidemiology 1996; 14: 317–359.
- Chen R.C., Chang S.F., Su C.L. et al. Prevalence, incidence, and mortality of PD. A door-to-door survey in Ilan County, Taiwan. Neurology 2001; 57: 1679–1686.
- Chio A., Magnani C., Tolardo G. et al. Parkinson’s disease: mortality in Italy, 1951 through 1987 – analysis of increasing trend. Arch.Neurol. 1993; 50: 149–153.
- DeRijk M.C., Tzourio C. Prevalence of parkinsonism and Parkinson’s disease in Europe: The Europarkinson Collaborative Study. J. Neurol. Neurosurg. Psychiatry 1997; 62: 10–15.
- Gelb D.J., Oliver E., Gilman S. Diagnostic criteria for Parkinson disease. Arch. Neurol. 1999; 56: 33–39.
- Gilman S. Maltiple system atrophy.In: J.Jankovic, E.Tolosa (eds). Parkinson’s disease and movement disorders, 3d ed. Baltimore: Williams&Wilkins, 1998: 245–262.
- Hoehn M.M., Yahr M.D. Parkinsonism: onset, progression and mortality. Neurology 1967; 17: 427–442.
- James H., Bower D.M., Maraganore M. et al. Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990. Neurology 1997; 49: 1284–1288.
- Litvan I., Agid Y., Calne D. et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson- Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996; 47: 1–9.
- McKeith I.G., Galasko D., Kosaka K. et al. Consensus guidlines for the clinical and pathologic diagnosis of dementia with Lewy bodies. Neurology 1996; 47 (Part I): 1113–1124.
- Olanow C.W., Jenner P. Dopamine agonises and neuroprotection in Parkinson’s disease. Ann Neurol. 1998; 44: 167–174.
- Rajput A.H., Offord K.P., Beard M. et al. Epidemiology of parkinsonism: incidence, classification, and mortality. Ann. Neurol. 1984; 16: 278–282.
- Rocca W.A., Bower A., Maraganore M. Time trends in the incidence of parkinsonism in Olmsted County, Minnesota. Neurology 2001; 57: 462–467.
- Schrag A., Ben-Shlomo Y., Quinn N.P. Cross sectional prevalence survey of idiopathic Parkinson’s disease and parkinsonism in London. BMJ 2000; 321: 21–22.
- Wang Y.S., Shi Y.M., Wu Z.Y. et al. Parkinson’s disease in China. Chin. Med. J. 1991; 104: 960–964.
- Wang S.J., Fuh J.L., Teng E.L. et al. A door-to-door survey of Parkinson’s disease in a Chinese population in Kinmen. Arch. Neurol. 1996; 53; 66–71.